Tenet seeks ‘win-win’ payer relationships but staying ‘diligent’ on denials: CFO

Advertisement

Dallas-based Tenet Healthcare is leaning on its revenue cycle management subsidiary, Conifer Health Solutions to protect revenue amid payer denials and shifting insurance coverage.

During Tenet’s Oct. 29 third-quarter earnings call, CFO Sun Park said the company remains focused on maximizing collections and responding to payer denials and other administrative challenges.

“From an operational basis, we try to have a win-win relationship with all our payers,” Mr. Park said. “We obviously have to be very diligent from our Conifer business operations on our revenue yield as we respond to different requests and, candidly, denial activity from the payers.”

He expressed confidence that Conifer’s capabilities and continued technology investments will help Tenet sustain its revenue cycle performance.

“We perform very well from a revenue yield basis, and that really has not changed over the last several years in our commentary,” he said. “We think given Conifer’s capabilities and the investments we continue to make in technology and Conifer overall, that we will be able to sustain that.”

The comments come as Tenet navigates pressure from declining health insurance exchange enrollment. Exchange admissions and revenue declined 18% year over year in the third quarter, creating an approximately 1.8% headwind to hospital revenue per adjusted admission.

However, commercial contracting remains a bright spot. Tenet continues to secure commercial rate renewals generally ranging from 3% to 5% and is more than 90% contracted for 2027, according to company executives. 

Tenet has increasingly turned to technology and automation to support its revenue cycle operations. In May, CEO Saum Sutaria, MD, said investments in AI and automation had more than doubled productivity for Conifer’s analytics team. The company was also identifying and piloting agentic workflows to improve business processes.

“We have included third-party EMR-integrated solutions which will increase our clinician productivity, decrease administrative burden, and improve patient access through programs such as AmbientScribe, automated discharge summaries, and autonomous professional fee coding in various pilot programs,” Dr. Sutaria said. 

Those investments are part of a broader effort to strengthen Conifer following Tenet’s move to regain full ownership of the business, as Chicago-based CommonSpirit exits the joint venture. Under the deal, CommonSpirit will pay about $1.9 billion to Tenet over the next two years, while Conifer will pay CommonSpirit roughly $540 million to redeem its 23.8% equity stake, effective Jan. 1. 

Tenet recognized a $147 million adjusted EBITDA benefit in the third quarter related to contract transition activities from Confier, including $97 million from revenue recognition timing and $50 million from other transition efficiencies. Tenet expects Conifer’s various contract transition activities to contribute about $450 million in adjusted EBITDA during 2026, but this is a benefit the company does not expect to recur in 2027.

“We are pleased with the results of this highly attractive Conifer transaction, as the total value generated from the contract sale will now increase to approximately 15x 2025 adjusted EBITDA minus [noncontrolling interest],” Dr. Sutaria said. “We have a transformed portfolio of businesses with strong underlying fundamentals, disciplined operations and a business mix which is diversified from many of the reimbursement headwinds that are affecting the industry.”

Advertisement

Next Up in Financial Management

Advertisement